Suppr超能文献

垂体腺瘤手术与焦虑障碍的相关性:系统评价和荟萃分析。

Correlation Between Pituitary Adenoma Surgery and Anxiety Disorder: Systematic Review and Meta-Analysis.

机构信息

Department of Neurologic Surgery, Pauline Braathen Neurologic Center, Cleveland Clinic Florida, Weston, Florida, USA.

Trauma Research Center, Shiraz University of Medical Sciences, Shiraz, Iran.

出版信息

World Neurosurg. 2024 Jul;187:184-193.e6. doi: 10.1016/j.wneu.2024.04.154. Epub 2024 Apr 30.

Abstract

OBJECTIVE

This study aims to evaluate the impact of surgical intervention on anxiety levels in patients with various types of pituitary adenoma (PA).

METHOD

A systematic review was conducted following PRISMA guidelines until October 2022, searching Embase, PubMed, Web of Sciences, and Scopus.

RESULTS

A total of 32 studies were included, encompassing 2,681 patients with the mean age of 53.33 ± 6.48 years (43.4% male). Among all subtypes, 664 diagnosed with Cushing's disease (25.8%), 612 with acromegaly (23.8%), 282 with prolactinoma (10.9%), and 969 with nonfunctional pituitary adenomas (37.6%). Pituitary insufficiency was the most common complication. Considering therapeutic modalities, 515 patients (29.8%) underwent endoscopic trans-sphenoidal surgery, while 222 (12.9%) underwent microscopic trans-sphenoidal surgery. The type of trans-sphenoidal surgery was not specified in 977 (56.6%) patients. A total of 17 studies including 1510 patients which mostly assessed anxiety using the Hospital Anxiety and Depression Scale (HADS) and Zung Self-Rating Anxiety Scale (SAS) were included in the meta-analysis. Preoperative evaluation using Hospital Anxiety and Depression Scale (HADS) questionnaire showed a pooled score of 8.27 (95%CI 4.54-12.01), while postoperative evaluation yielded a pooled score of 6.49 (95%CI 5.35-7.63), indicating no significant difference. Preoperative SAS assessment resulted in a pooled score of 50.43 (95%CI 37.40-63.45), with postoperative pooled score of 55.91 (95%CI 49.40-62.41), showing no significant difference.

CONCLUSIONS

Our analysis revealed no significant difference in anxiety scores pre- and postoperatively. While our findings suggest stability in anxiety levels following surgical intervention, it is imperative to recognize the limitations of the current evidence base. The observed lack of consensus may be influenced by factors such as the heterogeneous nature of the patient population, variations in the characteristics of pituitary adenomas, diverse therapeutic approaches, and potential confounding variables such as pre-existing mental health conditions and coping mechanisms. Further research is warranted to elucidate the nuanced relationship between surgical intervention for PA and anxiety outcomes, considering these complex interactions and employing rigorous methodologies to address potential sources of bias.

摘要

目的

本研究旨在评估外科干预对各种类型垂体腺瘤(PA)患者焦虑水平的影响。

方法

按照 PRISMA 指南进行系统评价,检索时间截至 2022 年 10 月,检索数据库包括 Embase、PubMed、Web of Sciences 和 Scopus。

结果

共纳入 32 项研究,共计 2681 例患者,平均年龄为 53.33±6.48 岁(43.4%为男性)。所有亚型中,664 例诊断为库欣病(25.8%),612 例为肢端肥大症(23.8%),282 例为催乳素瘤(10.9%),969 例为无功能垂体腺瘤(37.6%)。垂体功能减退是最常见的并发症。考虑治疗方式,515 例患者(29.8%)接受了经蝶窦内镜手术,222 例(12.9%)接受了经蝶窦显微镜手术。977 例患者(56.6%)未明确经蝶窦手术类型。共纳入 17 项研究,其中 1510 例患者主要采用医院焦虑抑郁量表(HADS)和zung 自评焦虑量表(SAS)评估焦虑,这些研究纳入了荟萃分析。术前采用 HADS 问卷评估焦虑,总分为 8.27(95%CI 4.54-12.01),术后总分为 6.49(95%CI 5.35-7.63),差异无统计学意义。术前 SAS 评分为 50.43(95%CI 37.40-63.45),术后评分为 55.91(95%CI 49.40-62.41),差异无统计学意义。

结论

本分析显示术前和术后焦虑评分无显著差异。尽管我们的研究结果表明手术干预后焦虑水平稳定,但需要认识到当前证据基础的局限性。观察到的缺乏共识可能受到多种因素的影响,包括患者人群的异质性、垂体腺瘤特征的差异、不同的治疗方法以及潜在的混杂因素,如术前心理健康状况和应对机制。需要进一步研究阐明 PA 的手术干预与焦虑结果之间的微妙关系,考虑到这些复杂的相互作用,并采用严格的方法来解决潜在的偏倚来源。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验